Recursion Pharmaceuticals Inc (RXRX) USD0.00001 A

Sell:$3.63Buy:$3.64Price increased$0.15 (4.10%)

NASDAQ:Price increased1.29%
Market closed |
Prices delayed by at least 15 minutes
Sell:$3.63
Buy:$3.64
Change:Price increased$0.15 (4.10%)
Market closed |
Prices delayed by at least 15 minutes
Sell:$3.63
Buy:$3.64
Change:Price increased$0.15 (4.10%)
Market closed |
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
19 February 2026
Christopher (Chris) GibsonChairman of the Board
Sell
Regular sell transaction (market)
40,000$3.46$138,400.00906,556
18 February 2026
Ben R TaylorCFO
Sell
Option/Award related
13,426$3.08$41,352.081,195,349
17 February 2026
Najat KhanChief Level Officer
Sell
Tax related
14,280$3.49$49,837.202,290,383
17 February 2026
Ben R TaylorCFO
Sell
Tax related
11,908$3.49$41,558.921,208,775
17 February 2026
David (Dave) HallettChief Level Officer
Sell
Tax related
11,908$3.49$41,558.921,097,151
17 February 2026
Christopher (Chris) GibsonChairman of the Board
Sell
Tax related
27,265$3.49$95,154.85906,556
6 February 2026
Najat KhanChief Level Officer
Sell
Tax related
10,364$3.98$41,248.722,304,663
6 February 2026
Ben R TaylorCFO
Sell
Tax related
11,400$3.98$45,372.001,220,683
6 February 2026
David (Dave) HallettChief Level Officer
Sell
Tax related
11,400$3.98$45,372.001,109,059
6 February 2026
Christopher (Chris) GibsonChairman of the Board
Sell
Tax related
10,364$3.56$36,895.84933,821

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
11 August 2025
Christopher (Chris) GibsonCEO
Sell
Regular sell transaction (market)
500,300$5.28$2,641,584.001,004,619
2 December 2025
Blake Charles BorgesonOther Level A
Sell
Regular sell transaction (market)
220,000$4.37$961,400.006,869,863
6 January 2026
Blake Charles BorgesonOther Level A
Sell
Regular sell transaction (market)
220,000$4.36$959,200.006,649,863
3 February 2026
Blake Charles BorgesonOther Level A
Sell
Regular sell transaction (market)
220,000$4.20$924,000.006,429,863
27 March 2025
Christopher (Chris) GibsonCEO
Sell
Regular sell transaction (market)
138,574$6.04$836,986.961,117,450

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.